Fenoterol Hydrobromide + Ipratropium Bromide (As Monohydrate) 1.25mg/500mcg Per 4ml Solution For Inhalation 1 Nebule

REMINDER: A doctor&rsquo,s prescription is required to purchase this product. To avoid delay in delivery or cancellation of your order ,(before the item is SHIPPED), please email a copy of your prescription (.jpeg or .pdf file format) to ,OnlinePharmacy@watsons.com.ph ,with your order number after Checkout. Our pharmacist will also get in touch with you to validate your prescription. Please be ready to show your original prescription upon claiming/delivery of your order.

 ,

 ,

 ,

Fenoterol hydrobromide/ipratropium bromide (Berodual F UDV) is a bronchodilator for the prevention and treatment of symptoms in chronic obstructive airway disorders with reversible airflow limitation such as bronchial asthma and especially chronic bronchitis with or without emphysema. Concomitant anti-inflammatory therapy should be considered for patients with bronchial asthma and steroid responsive chronic obstructive pulmonary disease (COPD).

Place of Origin

France

Product Usage

Treatment should be initiated and administered under medical supervision, e.g. in the hospital setting. Home based treatment can be recommended in exceptional cases (severe symptoms or experienced patients requiring higher doses) when a low dose rapid acting beta-agonist bronchodilator such as Berodual pressurised inhalation solution has been insufficient in providing relief after consultation with an experienced physician.

The treatment with the nebuliser solution in UDVs should always be started with the lowest recommended dose (1 UDV). In very severe cases two unit dose vials may be required for symptom relief. Administration should be stopped when sufficient symptom relief is achieved.

The following dosages are recommended for adults (including elderly patients) and adolescents

>, 12 years

Ingredients

1 unit dose vial contains 1.25 mg fenoterol hydrobromide and 500 mcg ipratropium bromide

Warnings

Contraindications:

Hypertrophic obstructive cardiomyopathy